Hong H. Yan

Incheon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Combination Therapy of the Active KRAS-Targeting Antibody inRas37 and a PI3K Inhibitor in Pancreatic Cancer.

Combination Therapy of the Active KRAS-Targeting Antibody inRas37 and a PI3K Inhibitor in Pancreatic Cancer.

Journal: Biomolecules & therapeutics

Published: September 07, 2021

ANGPTL4 accelerates KRASG12D-Induced acinar to ductal metaplasia and pancreatic carcinogenesis.

ANGPTL4 accelerates KRASG12D-Induced acinar to ductal metaplasia and pancreatic carcinogenesis.

Journal: Cancer letters

Published: May 05, 2021

Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape.

Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape.

Journal: Cancer letters

Published: November 17, 2020

PBT-6, a Novel PI3KC2γ Inhibitor in Rheumatoid Arthritis.

PBT-6, a Novel PI3KC2γ Inhibitor in Rheumatoid Arthritis.

Journal: Biomolecules & therapeutics

Published: September 18, 2019

ANGPTL4 exacerbates pancreatitis by augmenting acinar cell injury through upregulation of C5a.

ANGPTL4 exacerbates pancreatitis by augmenting acinar cell injury through upregulation of C5a.

Journal: EMBO molecular medicine

Published: July 29, 2019

An Integrative Data Mining and Omics-Based Translational Model for the Identification and Validation of Oncogenic Biomarkers of Pancreatic Cancer.

An Integrative Data Mining and Omics-Based Translational Model for the Identification and Validation of Oncogenic Biomarkers of Pancreatic Cancer.

Journal: Cancers

Published: December 14, 2018

HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer.

HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer.

Journal: Cancer letters

Published: October 04, 2018

KRAS targeting antibody synergizes anti-cancer activity of gemcitabine against pancreatic cancer.

KRAS targeting antibody synergizes anti-cancer activity of gemcitabine against pancreatic cancer.

Journal: Cancer letters

Published: June 29, 2018

Melatonin Synergizes with Sorafenib to Suppress Pancreatic Cancer via Melatonin Receptor and PDGFR-β/STAT3 Pathway.

Melatonin Synergizes with Sorafenib to Suppress Pancreatic Cancer via Melatonin Receptor and PDGFR-β/STAT3 Pathway.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: January 26, 2018

A novel tropomyosin-related kinase A inhibitor, KK5101 to treat pancreatic cancer.

A novel tropomyosin-related kinase A inhibitor, KK5101 to treat pancreatic cancer.

Journal: Cancer letters

Published: January 15, 2018

Artemisia Capillaris leaves inhibit cell proliferation and induce apoptosis in hepatocellular carcinoma.

Artemisia Capillaris leaves inhibit cell proliferation and induce apoptosis in hepatocellular carcinoma.

Journal: BMC complementary and alternative medicine

Published: October 13, 2017

Systematic assessment of cervical cancer initiation and progression uncovers genetic panels for deep learning-based early diagnosis and proposes novel diagnostic and prognostic biomarkers.

Systematic assessment of cervical cancer initiation and progression uncovers genetic panels for deep learning-based early diagnosis and proposes novel diagnostic and prognostic biomarkers.

Journal: Oncotarget

Published: September 15, 2017

Showing 1-12 of 32

Last Updated: 09/26/2026